Streptococcus pneumoniae-focused Research-grade Drug Discovery Service
Streptococcus pneumoniae is a prominent cause of a variety of infectious illnesses, including pneumonia and bacterial meningitis, as well as middle ear infections. With the increase of antibiotic-resistant strains, the need for new and effective drugs is increasingly critical. Creative Biolabs is committed to advancing scientific knowledge and contributing to drug discovery through innovative research services. One of our specialized offerings is our Streptococcus pneumoniae-focused research-grade drug discovery service.
Streptococcus Pneumoniae Overview
-
Shape. Streptococcus pneumoniae, frequently referred to as pneumococcus, is a type of gram-positive bacteria. These bacteria are spherical in shape and often arranged in pairs, hence getting the name "diplococci".
-
The capsule: One distinct characteristic of Streptococcus pneumoniae is its polysaccharide capsule, a major virulence factor, which aids in its evasion of the human immune system.
-
Natural habitat. Streptococcus pneumoniae primarily resides in the human nasopharynx. It normally stays there innocuously, but it can occasionally spread to other parts of the body and trigger infections.
-
Infections. When it does cause an infection, it can lead to serious diseases such as pneumonia, meningitis, and sepsis which can be life-threatening, especially in children and the elderly.
Our Comprehensive Service Highlight
-
Strain procurement & characterization. We have access to a wide range of Streptococcus pneumoniae strains and closely work on their characterization to support your research.
-
In vitro testing. Our advanced laboratory facilities enable us to carry out exhaustive in vitro testing to screen potential drug candidates against multiple Streptococcus pneumoniae strains.
-
High-throughput screening (HTS). We utilize HTS technologies to swiftly and efficiently identify promising drug candidates from a broad spectrum of chemical entities.
-
Mode of action studies. We offer MoA studies to help understand the interaction between the identified drug candidates and the Streptococcus pneumoniae strain.
-
ADME profiling. Our ADME (Absorption, Distribution, Metabolism, and Excretion) services help ensure your potential drug's safety and efficacy.
-
Preclinical testing. We offer end-to-end services including in vivo efficacy, pharmacokinetics, and toxicology studies in relevant animal models.
By partnering with us, researchers and pharmaceutical companies can have access to our Streptococcus pneumoniae-focused drug discovery platform and fast-track the drug discovery process without having to invest in in-house capabilities and deal with resource and time constraints. At Creative Biolabs, we assure you of our tireless dedication to your project, stringent quality controls, and project completion guaranteed by our in-depth operational and therapeutic understanding. Please contact us with your Streptococcus pneumoniae-themed drug discovery projects to fast-forward the therapeutic intervention against this pathogen.
For Research Use Only. We do not provide direct services or products for patients.
Related Services:
